NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)

CompletedPhase 2

Sponsor: Ottawa Heart Institute Research Corporation

Conditions: Atherosclerosis

Interventions: Clopidogrel 75 mg daily, water pill daily

Countries: Canada

The purpose of this study is to determine whether the combination of clopidogrel with aspirin prevents the development of blockages (atherosclerosis) in vein grafts one year after coronary artery bypass surgery (CABG) compared to aspirin alone.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients undergoing primary multi-vessel CABG with at least two saphenous vein grafts, with or without the use of cardiopulmonary bypass.

Exclusion Criteria:

* Emergency surgery
* Valve surgery
* Redo CABG
* Left ventricle ejection fraction \< 25%
* Serum creatinine \> 130 µmol/L
* Preoperative use of clopidogrel (with the exception of the current admission)
* Preoperative use of warfarin; allergy to aspirin or clopidogrel.
* History of cerebrovascular accident
* History of severe liver disease
* Morbid obesity
* Current malignancy

Locations (1)

Ottawa, Ontario, Canada